Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aspirin + cyclosporine is a combination of two small molecule drugs, each with distinct mechanisms of action. Aspirin (acetylsalicylic acid) is a non-selective cyclooxygenase (COX) inhibitor used for its analgesic, antipyretic, anti-inflammatory, and antiplatelet effects. Cyclosporine is an immunosuppressant that acts as a calcineurin inhibitor to prevent organ transplant rejection and treat autoimmune diseases by suppressing T-cell activation. This combination does not have a unique brand or product name and is not marketed as a fixed-dose formulation; it refers to the concurrent use of both agents in clinical practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aspirin + cyclosporine.